Welcome to GENOMED Licensed Laboratory for Genetics and Molecular Pathology Know more GenoMed® participated in the 2021 EMQN CIC* EQA schemes for
Lung cancer (NSCLC) (Tissue) 2021 and PIK3CA testing in breast cancer.
EMQN CIC’s assessment of our clinical reports considered them to be of a high standard and they were
selected by EMQN to be used as educational examples of good reporting practice for member access on their website.
We proudly share this news and would like to take this opportunity to thank everyone for their support in
making GenoMed® a successful company!
*EMQN CIC is the largest global provider of genomics external quality assessment / proficiency testing. Lung Cancer Gene PIK3CA

Search for Gene or Disease

Generic selectors
Exact matches only
Search in title
Search in content

a DNA, a PERSON, a TEST

GenoMed® makes the difference through establishing a doctor/laboratory proximity relationship, working together to select the most appropriate test for each patient. Our main objective is to facilitate diagnoses and personalised therapeutic options, from a molecular point of view, for a wide range of diseases, including rare, cardiovascular, or oncological diseases.

We acknowledge the importance of following scientific and technological developments in order to accomplish Precision Medicine. Thus, we work in an Open Innovation format, being able to analyse any gene, regardless of the rarity of the associated disease. At the same time, we are always available to create new panels or customize existing panels, making them individual and specific, even for more complex cases.

testeadn_home_semfundo
mkdf-eliptic-slider

Quality
Services

CLINICAL TESTS

– Molecular Tests
– NGS Panels
– Exomes

mkdf-eliptic-slider

Quality
Services

NON-CLINICAL TESTS

– Ancestry
– Paternity

Research projects co-funded by:

Genomed - SI IDT 24136 - Barra de assinaturas FEDER.JPG

Contact us for more information